Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study
نویسندگان
چکیده
منابع مشابه
Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
CONTEXT AND OBJECTIVE The presence of a certain degree of inflammation in the gut wall is now accepted in irritable bowel syndrome (IBS). Fecal calprotectin is considered to be a reliable test for detecting intestinal inflammation. Our aim was to assess the presence of inflammation in postinfectious IBS (PI-IBS), compared with non-postinfectious IBS (NPI-IBS). A secondary objective was to deter...
متن کاملPathogenic Factors in Postinfectious Irritable Bowel Syndrome - an Update
Teodora Iacob, Doina F. Țățulescu, Cristina Cijevschi Prelipcean, D. L. Dumitrașcu University of Medicine and Pharmacy ”Iuliu Hațieganu“-Cluj-Napoca Faculty of Medicine 1. Department of Infectious Diseases 3. Medical Department University of Medicine and Pharmacy “Grigore T. Popa”-Iaşi Faculty of Medicine 3. Department of Medical Specialties (I) *Corresponding author. E-mail: ddumitrascu@umfclu...
متن کاملAlteration of Fecal Microbiota in Patients With Postinfectious Irritable Bowel Syndrome
CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. *Correspondence: Young-Eun Joo, MD, PhD Department of Internal Medicine, Chonnam Nationa...
متن کاملTherapy of the postinfectious irritable bowel syndrome: an update
After acute infectious gastroenteritis, up to thirty percent of patients present prolonged gastrointestinal symptoms and a part of those affected patients can have the diagnostic criteria for postinfectious irritable bowel syndrome. Treatment is symptom directed rather than curative and includes agents prescribed for the treatment of irritable bowel syndrome in general. Prophylaxis or early tre...
متن کاملTreatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine.
CONTEXT Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition. The effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sao Paulo Medical Journal
سال: 2014
ISSN: 1806-9460,1516-3180
DOI: 10.1590/1516-3180.2014.8000815